Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Metadata
Title
Limited Capacity for Ammonia Removal by Brain in Chronic Liver Failure: Potential Role of Nitric Oxide
Authors
Christopher Rose
Vicente Felipo
Publication date
01-12-2005
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Metabolic Brain Disease / Issue 4/2005
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-005-7906-4

Other articles of this Issue 4/2005

Metabolic Brain Disease 4/2005 Go to the issue

OriginalPaper

Role of Phosphate-Activated Glutaminase in the Pathogenesis of Hepatic Encephalopathy

OriginalPaper

Introduction

OriginalPaper

Which Are the Right Cells to be Used in a Bioartificial Liver?

OriginalPaper

Molecular Mechanisms of the Alterations in NMDA Receptor-Dependent Long-Term Potentiation in Hyperammonemia

OriginalPaper

Role of Endogenous Benzodiazepine Ligands and Their GABA-A-Associated Receptors in Hepatic Encephalopathy

OriginalPaper

Altered Modulation of Motor Activity by Group I Metabotropic Glutamate Receptors in the Nucleus Accumbens in Hyperammonemic Rats